Ngā hua rapu - Greg Golm

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine

    Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine mā Christophe Fraser, Joanne E. Tomassini, Liwen Xi, Greg Golm, Michael Watson, Anna R. Giuliano, Eliav Barr, Kevin A. Ault

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Impact of Baseline Covariates on the Immunogenicity of a Quadrivalent (Types 6, 11, 16, and 18) Human Papillomavirus Virus‐Like‐Particle Vaccine

    Impact of Baseline Covariates on the Immunogenicity of a Quadrivalent (Types 6, 11, 16, and 18) Human Papillomavirus Virus‐Like‐Particle Vaccine mā Anna R. Giuliano, Eduardo Lazcano‐Ponce, Luisa L. Villa, Terry Nolan, Colin D. Marchant, David Radley, Greg Golm, Kathleen McCarroll, Jimmy Yu, Mark T. Esser, Scott Vuocolo, Eliav Barr

    I whakaputaina 2007
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: